Clinical Trial Update: EXACERBATIONS AND REAL-WORLD OUTOMES AMONG PATIENTS WITH COPD INITIATING BREZTRI (EROS+CP Japan Study)

View source ↗

Summary

The completed EROS+CP Japan Study reports real-world outcomes and COPD exacerbations among patients in Japan starting Breztri (budesonide/glycopyrronium/formote…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Breztri (budesonide/glycopyrronium/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED